TriSalus Life Sciences, Inc.TLSINASDAQ
Loading
SG&A Expense Growth Recovery in ProgressRecovering
Percentile Rank40
3Y CAGR-33.0%
Year-over-Year Change
Year-over-year SG&A expense growth
3Y CAGR
-33.0%/yr
Annual compound
Percentile
P40
Within normal range
vs 3Y Ago
0.3x
Contraction
Streak
1 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2025 | 14.52% |
| 2024 | 8.04% |
| 2023 | 60.76% |
| 2022 | 48.22% |
| 2021 | 15583.96% |
| 2020 | 0.00% |